Mo-Im Nursing Research Institute, College of Nursing, Yonsei University, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
Department of Nursing, School of Nursing and Midwifery, University of Health and Allied Sciences, Ho, Ghana.
BMC Health Serv Res. 2022 Dec 31;22(1):1601. doi: 10.1186/s12913-022-08927-x.
Globally, breast cancer is the most common cancer type and the leading cause of cancer mortality among women in developing countries. A high prevalence of late breast cancer diagnosis and treatment has been reported predominantly in Low- and Middle-Income Countries (LMICs), including those in Asia. Thus, this study utilized a mixed-methods systematic review to synthesize the health system barriers influencing timely breast cancer diagnosis and treatment among women in Asian countries.
We systematically searched five electronic databases for studies published in English from 2012 to 2022 on health system barriers that influence timely breast cancer diagnosis and treatment among women in Asian countries. The review was conducted per the methodology for systematic reviews and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, while health system barriers were extracted and classified based on the World Health Organization (WHO)'s Health Systems Framework. The mixed-methods appraisal tool was used to assess the methodological quality of the included studies.
Twenty-six studies were included in this review. Fifteen studies were quantitative, nine studies were qualitative, and two studies used a mixed-methods approach. These studies were conducted across ten countries in Asia. This review identified health systems barriers that influence timely breast cancer diagnosis and treatment. The factors were categorized under the following: (1) delivery of health services (2) health workforce (3) financing for health (4) health information system and (5) essential medicines and technology. Delivery of health care (low quality of health care) was the most occurring barrier followed by the health workforce (unavailability of physicians), whilst health information systems were identified as the least barrier.
This study concluded that health system factors such as geographical accessibility to treatment, misdiagnosis, and long waiting times at health facilities were major barriers to early breast cancer diagnosis and treatment among Asian women in LMICs. Eliminating these barriers will require deliberate health system strengthening, such as improving training for the health workforce and establishing more healthcare facilities.
在全球范围内,乳腺癌是最常见的癌症类型,也是发展中国家女性癌症死亡的主要原因。中低收入国家(LMICs),包括亚洲国家,报告了晚期乳腺癌诊断和治疗的高患病率。因此,本研究采用混合方法系统评价,综合分析影响亚洲国家女性及时进行乳腺癌诊断和治疗的卫生系统障碍。
我们系统地检索了五个英文电子数据库,以获取 2012 年至 2022 年期间发表的关于影响亚洲国家女性及时进行乳腺癌诊断和治疗的卫生系统障碍的研究。该评价按照系统评价的方法进行,并按照系统评价和荟萃分析的首选报告项目(PRISMA)指南进行报告,同时根据世界卫生组织(WHO)的卫生系统框架提取和分类卫生系统障碍。使用混合方法评价工具评估纳入研究的方法学质量。
本综述共纳入 26 项研究。其中 15 项为定量研究,9 项为定性研究,2 项为混合方法研究。这些研究在亚洲十个国家进行。本综述确定了影响及时进行乳腺癌诊断和治疗的卫生系统障碍。这些因素分为以下几类:(1)卫生服务的提供(2)卫生人力(3)卫生筹资(4)卫生信息系统和(5)基本药物和技术。卫生服务的提供(医疗质量低)是最常见的障碍,其次是卫生人力(缺乏医生),而卫生信息系统被认为是最少的障碍。
本研究得出结论,卫生系统因素,如治疗的地理可及性、误诊和在卫生设施的长时间等待,是中低收入国家亚洲女性早期乳腺癌诊断和治疗的主要障碍。消除这些障碍需要有针对性地加强卫生系统,例如提高卫生人力的培训和建立更多的医疗保健设施。